Professor Ross Andrews
PhD, Australian National University, 2004; Master of Applied Epidemiology, Australian National University, 1998; Master of Public Health, Monash University, 1995; Diploma of Applied Science (Environmental Health), Swinburne University, 1984.
Approved level of HDR supervision at Charles Darwin University:
Principal Supervisor for PhD
Professor Andrews is an epidemiologist with major research interests in vaccine-preventable diseases and skin infections.
He is a senior member of the Australian Partnership for Preparedness Research on InfectiouS disease Emergencies (APPRISE) and has a joint appointment as Director of the Masters of Applied Epidemiology (MAE) program at the Australian National University. The MAE is Australia’s field epidemiology training program. Ross has contributed to national immunisation policy for 10 years as a member the Australian Technical Advisory Group on Immunisation (ATAGI), including four years as Chair. His term on ATAGI ended on 30 June 2018.
Ross has $24.2m in research funding; 116 peer-reviewed publications; supervised 11 higher degree by research (HDR) students to completion (five as primary supervisor) and currently supervises five HDR students.
- Assessment of Heat Stress and Recommendations for Management: McArthur River Mine
- A randomised controlled trial of alternative treatments to intramuscular penicillin for impetigo in Aboriginal children
- Beating scabies and strongyloides in Galiwin'ku
- Vitamin D and acute lower respiratory tract infection in Indigenous children
- FluMum: a prospective cohort study of mother-infant pairs assessing the effectiveness of maternal influenza vaccination in prevention of influenza in early infancy
- A cluster RCT of the impact of a community-based hygiene and sanitation programme on infection with intestinal parasites following mass albendazole chemotherapy in Timor-Leste
- An RCT of alternative mass drug administration program (oral ivermectin versus topical permethrin) in Fiji
- Community-based surveillance of bacterial respiratory pathogens in the Northern Territory and Western Australia.
Mchugh L, Marshall HS, Perrett KP Nolan T, Wood N, Lambert SB, Richmond P, Ware RS, Binks P, Binks MJ, Andrews RM (2018). The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study. Clin Infect Dis. 2018 Nov 23. doi: 10.1093/cid/ciy517.
- Moberley, S., Holden, J., Tatham, D. & Andrews, R. (2013). Vaccines for preventing pneumococcal infection in adults (Review). Cochrane Database of Systematic Reviews, 1, CD000422.
- Kearns, T., Clucas, D., Connors, C., Currie, B., Carapetis, J. & Andrews, R. (2013). Clinic Attendances during the First 12 Months of Life for Aboriginal Children in Five Remote Communities of Northern Australia. PLoS One, 8(3), e58231.
- Snelling, T., Andrews, R., Kirkwood, D., Culvenor, S. & Carapetis, J. (2011). Case-Control Evaluation of the Effectiveness of the G1P Human Rotavirus Vaccine during an Outbreak of Rotavirus G2P4 Infection in Central Australia. Clinical Infectious Diseases, 52(2), 191-199.
- O’Grady, K.A., Lee, K., Carlin, J., Torzillo, P., Change, A.B., Mulholland, E.K., Lambert, S. & Andrews, R. (2010). Increased risk of hospitalization for acute lower respiratory tract infection among Australian indigenous infant 5-23 month of age following pneumococcal vaccination: a cohort study. Clinical Infectious Diseases, 50(7), 970-978.
- O’Grady, K.A., Carlin, J., Chang, A.B., Torzillo, P., Noaln, T., Ruben, A. & Andrews, R. (2010). Effectiveness of 7-valent pneumococcal conjugate vaccine against radiologically diagnosed pneumonia in indigenous infants in Australia. World Health Organization Bulletin, 88(2). 139-146.
- Moberley, S., Krause, V., Cook, H., Mulholland, E.K., Carapetis, J., Torzillo, P. & Andrews, R. (2010). Failure to vaccinate or failure of vaccine? Effectiveness of the 23-valent pneumococcal plysaccharide vaccine program in Indigenous adults in the Northern Territory of Australia. Vaccine, 28(11), 2296-2301
- O’Grady, K.A., Krause, V. & Andrews, R. (2009). Immunisation coverage in Australian Indigenous children: Time to move the goal posts. Vaccine, 27(2), 307-312.
- Dunbar, M., Moberley, S., Nelson, S., Leach, A. & Andrews, R. (2007). Clear not simple: An approach to community consultation for a maternal pneumococcal vaccine trial among Indigenous women in the Northern Territory of Australia. Vaccine, 25(13), 2385-2388.
- Skull, S., Andrews, R., Byrnes, G., Kelly, H., Nolan, T., Brown, G. & Campbell, D. (2007). Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: Benefit due to influenza and pneumococcal vaccination not demonstrated. Vaccine 25(23), 4631-4640.
Click here to view more Ross Andrews publications in PubMed.
Researchers across Australia will work together to study an emerging virus that has caused three outbreaks of serious illness in infants since 2013. Parechovirus can cause sepsis-like and meningitis-like infection leading to developmental delays in severe cases.
APPRISE researcher Professor Ross Andrews, an epidemiologist at the Menzies School of Health Research in Darwin, said effective and respectful engagement with communities rather than for them is critical to effective preparation for future pandemics.
WORKERS at the Northern Territory’s McArthur River Mine will be the guinea pigs for a study by Menzies School of Health to determine the effects of heat stress on productivity.
The Scabies Research Team, from Murdoch Childrens Research Institute; the Kirby Institute; St Vincent's Hospital Sydney; and Menzies School of Health Research, wins the 2017 Australian Infectious Diseases Research Centre Eureka Prize for Infectious Diseases Research.
Almost 2500 women had the vaccination, while more than 4600 opted not to. Menzies School of Health Research PhD student and lead author Lisa McHugh said they found no clinically significant differences in infants’ birthweight or gestational age at birth between the two groups of women.
An Australia-wide study published in the international journal Vaccine has provided reassuring evidence on the safety of influenza vaccination during pregnancy.
In a world-first study, treatment of a whole community with oral ivermectin has been shown to virtually eliminate scabies, providing new hope in the fight to control this debilitating disease.
A Menzies research project is part of ten of the best health and medical research projects underway in Australia today.
A NT-based research project investigating the effectiveness of a vaccine to prevent severe diarrhoea in children has been recognised as one of the country’s ten best research projects for 2013.
Federal Minister for Indigenous Affairs Warren Snowdon and Northern Territory Minister for Health Kon Vatskalis have turned the ‘first sod’ in celebration of the Menzies School of Health Research new multimillion dollar building project.
The Menzies School of Health Research is hoping the drug Ivermectin will rid the Echo Island community, east of Darwin, of scabies and the strongyloides worm.